| Dr Samantha Tuczynski, MD | |
|
300 E Warwick Dr, Alma, MI 48801-1014 | |
| (989) 466-3228 | |
| Not Available |
| Full Name | Dr Samantha Tuczynski |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 7 Years |
| Location | 300 E Warwick Dr, Alma, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770077943 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 4301115846 (Michigan) | Secondary |
| 207P00000X | Emergency Medicine | 4301501931 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Midmichigan Medical Center-clare | Clare, MI | Hospital |
| Midmichigan Medical Center-gratiot | Alma, MI | Hospital |
| Midmichigan Medical Center-west Branch | West branch, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mclaren Medical Group | 3971416082 | 187 |
| Mymichigan Medical Center Alma | 3375451404 | 82 |
| Mymichigan Medical Center Clare | 7012829773 | 97 |
| Mymichigan Medical Center West Branch | 7214251081 | 49 |
News Archive
Abington Health, Aria Health and Einstein Healthcare Network announced today the development of a new initiative that will enable the three health systems to work collaboratively while remaining independent as they prepare for the demands of national health reform.
Celltrion, Inc., a South Korean biopharmaceutical company, has developed novel human monoclonal antibodies against influenza virus infection, which neutralize a broad spectrum of influenza viruses, including pandemic H1N1 and the deadly H5N1 avian influenza virus. Preliminary tests in laboratory animals indicate that the novel human monoclonal antibodies can be used to prevent disease when given either before or after infection.
Humiliation in physical education class as a child can turn people off fitness for good, according to a University of Alberta researcher.
"There are so many things we take for granted in America. One of them is that our children are not regularly infected by one of the tropical diseases so common among the world's poorest people," Richard Besser, ABC News' chief health and medical editor, writes in an ABC News opinion piece.
Abbott today announced the European approval and launch of its TREK™ Coronary Dilatation Catheter for the treatment of coronary artery disease. The TREK system represents a new approach to balloon catheter design, and provides physicians with a high-performing option for treating challenging lesions and difficult-to-reach blockages. Abbott received CE Mark for the TREK system earlier this year.
› Verified 3 days ago
| Entity Name | Mclaren Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346396066 PECOS PAC ID: 3971416082 Enrollment ID: O20031106000025 |
News Archive
Abington Health, Aria Health and Einstein Healthcare Network announced today the development of a new initiative that will enable the three health systems to work collaboratively while remaining independent as they prepare for the demands of national health reform.
Celltrion, Inc., a South Korean biopharmaceutical company, has developed novel human monoclonal antibodies against influenza virus infection, which neutralize a broad spectrum of influenza viruses, including pandemic H1N1 and the deadly H5N1 avian influenza virus. Preliminary tests in laboratory animals indicate that the novel human monoclonal antibodies can be used to prevent disease when given either before or after infection.
Humiliation in physical education class as a child can turn people off fitness for good, according to a University of Alberta researcher.
"There are so many things we take for granted in America. One of them is that our children are not regularly infected by one of the tropical diseases so common among the world's poorest people," Richard Besser, ABC News' chief health and medical editor, writes in an ABC News opinion piece.
Abbott today announced the European approval and launch of its TREK™ Coronary Dilatation Catheter for the treatment of coronary artery disease. The TREK system represents a new approach to balloon catheter design, and provides physicians with a high-performing option for treating challenging lesions and difficult-to-reach blockages. Abbott received CE Mark for the TREK system earlier this year.
› Verified 3 days ago
| Entity Name | Mymichigan Medical Center Alma |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265596126 PECOS PAC ID: 3375451404 Enrollment ID: O20040202000975 |
News Archive
Abington Health, Aria Health and Einstein Healthcare Network announced today the development of a new initiative that will enable the three health systems to work collaboratively while remaining independent as they prepare for the demands of national health reform.
Celltrion, Inc., a South Korean biopharmaceutical company, has developed novel human monoclonal antibodies against influenza virus infection, which neutralize a broad spectrum of influenza viruses, including pandemic H1N1 and the deadly H5N1 avian influenza virus. Preliminary tests in laboratory animals indicate that the novel human monoclonal antibodies can be used to prevent disease when given either before or after infection.
Humiliation in physical education class as a child can turn people off fitness for good, according to a University of Alberta researcher.
"There are so many things we take for granted in America. One of them is that our children are not regularly infected by one of the tropical diseases so common among the world's poorest people," Richard Besser, ABC News' chief health and medical editor, writes in an ABC News opinion piece.
Abbott today announced the European approval and launch of its TREK™ Coronary Dilatation Catheter for the treatment of coronary artery disease. The TREK system represents a new approach to balloon catheter design, and provides physicians with a high-performing option for treating challenging lesions and difficult-to-reach blockages. Abbott received CE Mark for the TREK system earlier this year.
› Verified 3 days ago
| Entity Name | Mckenzie Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497750608 PECOS PAC ID: 6406755289 Enrollment ID: O20040310000552 |
News Archive
Abington Health, Aria Health and Einstein Healthcare Network announced today the development of a new initiative that will enable the three health systems to work collaboratively while remaining independent as they prepare for the demands of national health reform.
Celltrion, Inc., a South Korean biopharmaceutical company, has developed novel human monoclonal antibodies against influenza virus infection, which neutralize a broad spectrum of influenza viruses, including pandemic H1N1 and the deadly H5N1 avian influenza virus. Preliminary tests in laboratory animals indicate that the novel human monoclonal antibodies can be used to prevent disease when given either before or after infection.
Humiliation in physical education class as a child can turn people off fitness for good, according to a University of Alberta researcher.
"There are so many things we take for granted in America. One of them is that our children are not regularly infected by one of the tropical diseases so common among the world's poorest people," Richard Besser, ABC News' chief health and medical editor, writes in an ABC News opinion piece.
Abbott today announced the European approval and launch of its TREK™ Coronary Dilatation Catheter for the treatment of coronary artery disease. The TREK system represents a new approach to balloon catheter design, and provides physicians with a high-performing option for treating challenging lesions and difficult-to-reach blockages. Abbott received CE Mark for the TREK system earlier this year.
› Verified 3 days ago
| Entity Name | Mymichigan Medical Center Alpena |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508332792 PECOS PAC ID: 8527969922 Enrollment ID: O20040415000495 |
News Archive
Abington Health, Aria Health and Einstein Healthcare Network announced today the development of a new initiative that will enable the three health systems to work collaboratively while remaining independent as they prepare for the demands of national health reform.
Celltrion, Inc., a South Korean biopharmaceutical company, has developed novel human monoclonal antibodies against influenza virus infection, which neutralize a broad spectrum of influenza viruses, including pandemic H1N1 and the deadly H5N1 avian influenza virus. Preliminary tests in laboratory animals indicate that the novel human monoclonal antibodies can be used to prevent disease when given either before or after infection.
Humiliation in physical education class as a child can turn people off fitness for good, according to a University of Alberta researcher.
"There are so many things we take for granted in America. One of them is that our children are not regularly infected by one of the tropical diseases so common among the world's poorest people," Richard Besser, ABC News' chief health and medical editor, writes in an ABC News opinion piece.
Abbott today announced the European approval and launch of its TREK™ Coronary Dilatation Catheter for the treatment of coronary artery disease. The TREK system represents a new approach to balloon catheter design, and provides physicians with a high-performing option for treating challenging lesions and difficult-to-reach blockages. Abbott received CE Mark for the TREK system earlier this year.
› Verified 3 days ago
| Entity Name | Mymichigan Medical Center Clare |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134394026 PECOS PAC ID: 7012829773 Enrollment ID: O20080721000628 |
News Archive
Abington Health, Aria Health and Einstein Healthcare Network announced today the development of a new initiative that will enable the three health systems to work collaboratively while remaining independent as they prepare for the demands of national health reform.
Celltrion, Inc., a South Korean biopharmaceutical company, has developed novel human monoclonal antibodies against influenza virus infection, which neutralize a broad spectrum of influenza viruses, including pandemic H1N1 and the deadly H5N1 avian influenza virus. Preliminary tests in laboratory animals indicate that the novel human monoclonal antibodies can be used to prevent disease when given either before or after infection.
Humiliation in physical education class as a child can turn people off fitness for good, according to a University of Alberta researcher.
"There are so many things we take for granted in America. One of them is that our children are not regularly infected by one of the tropical diseases so common among the world's poorest people," Richard Besser, ABC News' chief health and medical editor, writes in an ABC News opinion piece.
Abbott today announced the European approval and launch of its TREK™ Coronary Dilatation Catheter for the treatment of coronary artery disease. The TREK system represents a new approach to balloon catheter design, and provides physicians with a high-performing option for treating challenging lesions and difficult-to-reach blockages. Abbott received CE Mark for the TREK system earlier this year.
› Verified 3 days ago
| Entity Name | Mymichigan Medical Center West Branch |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538566765 PECOS PAC ID: 7214251081 Enrollment ID: O20160714002424 |
News Archive
Abington Health, Aria Health and Einstein Healthcare Network announced today the development of a new initiative that will enable the three health systems to work collaboratively while remaining independent as they prepare for the demands of national health reform.
Celltrion, Inc., a South Korean biopharmaceutical company, has developed novel human monoclonal antibodies against influenza virus infection, which neutralize a broad spectrum of influenza viruses, including pandemic H1N1 and the deadly H5N1 avian influenza virus. Preliminary tests in laboratory animals indicate that the novel human monoclonal antibodies can be used to prevent disease when given either before or after infection.
Humiliation in physical education class as a child can turn people off fitness for good, according to a University of Alberta researcher.
"There are so many things we take for granted in America. One of them is that our children are not regularly infected by one of the tropical diseases so common among the world's poorest people," Richard Besser, ABC News' chief health and medical editor, writes in an ABC News opinion piece.
Abbott today announced the European approval and launch of its TREK™ Coronary Dilatation Catheter for the treatment of coronary artery disease. The TREK system represents a new approach to balloon catheter design, and provides physicians with a high-performing option for treating challenging lesions and difficult-to-reach blockages. Abbott received CE Mark for the TREK system earlier this year.
› Verified 3 days ago
| Entity Name | Degara App Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265976971 PECOS PAC ID: 7618251398 Enrollment ID: O20170223001941 |
News Archive
Abington Health, Aria Health and Einstein Healthcare Network announced today the development of a new initiative that will enable the three health systems to work collaboratively while remaining independent as they prepare for the demands of national health reform.
Celltrion, Inc., a South Korean biopharmaceutical company, has developed novel human monoclonal antibodies against influenza virus infection, which neutralize a broad spectrum of influenza viruses, including pandemic H1N1 and the deadly H5N1 avian influenza virus. Preliminary tests in laboratory animals indicate that the novel human monoclonal antibodies can be used to prevent disease when given either before or after infection.
Humiliation in physical education class as a child can turn people off fitness for good, according to a University of Alberta researcher.
"There are so many things we take for granted in America. One of them is that our children are not regularly infected by one of the tropical diseases so common among the world's poorest people," Richard Besser, ABC News' chief health and medical editor, writes in an ABC News opinion piece.
Abbott today announced the European approval and launch of its TREK™ Coronary Dilatation Catheter for the treatment of coronary artery disease. The TREK system represents a new approach to balloon catheter design, and provides physicians with a high-performing option for treating challenging lesions and difficult-to-reach blockages. Abbott received CE Mark for the TREK system earlier this year.
› Verified 3 days ago
| Entity Name | Epmg Southern Michigan Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336607126 PECOS PAC ID: 0941536114 Enrollment ID: O20190725001424 |
News Archive
Abington Health, Aria Health and Einstein Healthcare Network announced today the development of a new initiative that will enable the three health systems to work collaboratively while remaining independent as they prepare for the demands of national health reform.
Celltrion, Inc., a South Korean biopharmaceutical company, has developed novel human monoclonal antibodies against influenza virus infection, which neutralize a broad spectrum of influenza viruses, including pandemic H1N1 and the deadly H5N1 avian influenza virus. Preliminary tests in laboratory animals indicate that the novel human monoclonal antibodies can be used to prevent disease when given either before or after infection.
Humiliation in physical education class as a child can turn people off fitness for good, according to a University of Alberta researcher.
"There are so many things we take for granted in America. One of them is that our children are not regularly infected by one of the tropical diseases so common among the world's poorest people," Richard Besser, ABC News' chief health and medical editor, writes in an ABC News opinion piece.
Abbott today announced the European approval and launch of its TREK™ Coronary Dilatation Catheter for the treatment of coronary artery disease. The TREK system represents a new approach to balloon catheter design, and provides physicians with a high-performing option for treating challenging lesions and difficult-to-reach blockages. Abbott received CE Mark for the TREK system earlier this year.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Samantha Tuczynski, MD 300 E Warwick Dr, Alma, MI 48801-1014 Ph: (989) 463-1101 | Dr Samantha Tuczynski, MD 300 E Warwick Dr, Alma, MI 48801-1014 Ph: (989) 466-3228 |
News Archive
Abington Health, Aria Health and Einstein Healthcare Network announced today the development of a new initiative that will enable the three health systems to work collaboratively while remaining independent as they prepare for the demands of national health reform.
Celltrion, Inc., a South Korean biopharmaceutical company, has developed novel human monoclonal antibodies against influenza virus infection, which neutralize a broad spectrum of influenza viruses, including pandemic H1N1 and the deadly H5N1 avian influenza virus. Preliminary tests in laboratory animals indicate that the novel human monoclonal antibodies can be used to prevent disease when given either before or after infection.
Humiliation in physical education class as a child can turn people off fitness for good, according to a University of Alberta researcher.
"There are so many things we take for granted in America. One of them is that our children are not regularly infected by one of the tropical diseases so common among the world's poorest people," Richard Besser, ABC News' chief health and medical editor, writes in an ABC News opinion piece.
Abbott today announced the European approval and launch of its TREK™ Coronary Dilatation Catheter for the treatment of coronary artery disease. The TREK system represents a new approach to balloon catheter design, and provides physicians with a high-performing option for treating challenging lesions and difficult-to-reach blockages. Abbott received CE Mark for the TREK system earlier this year.
› Verified 3 days ago
Dr. George Michael Elliott, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 E Warwick Dr, Alma, MI 48801 Phone: 989-331-7940 | |
Joseph David Peterson, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 E Warwick Dr, Alma, MI 48801 Phone: 989-463-1101 | |
Samuel Robles, DO Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 300 South Warwick Dr, Alma, MI 48801 Phone: 989-463-1101 |